The Role of Patient Advocates in Comprehensive Medication Management (CMM) - Key to Patient Engagement
Start Date: December 03, 2014
End Date: December 03, 2014
Wed, Dec 3, 2014 1:30 PM - 3:00 PM EST
Comprehensive Medication Management (CMM), is a standard of care that ensures each patient’s medications (whether they are prescription, nonprescription, alternative, traditional, vitamins, or nutritional supplements) are individually assessed to determine that each medication is appropriate for the patient, effective for the medical condition, safe given the co-morbidities and other medications being taken, and able to be taken by the patient as intended. When this standard is used in patient center care there is greater likelihood that the intended goals of treatment are achieved.
This ePALS webinar will provide patient advocates a better understanding of CMM and how common goals of the patient and providers can be brought together to serve to drive efficiencies and improve effectiveness while decreasing costs of care. Advocates will learn how they may use this knowledge to effect policy and programs that reduce the impact of chronic disease by improving care coordination. In addition, they will be provided examples of legislation that addresses CMM and care coordination.
This ePALS webinar is part of the PALS (Patient Advocacy Leaders Summit ) program, which involves patient advocates from around the country. PALS was developed by GlaxoSmithKline in 2002 and is designed to bring together diverse patient advocacy leaders to improve their advocacy capacity and effectiveness by learning from experts from the fields of advocacy, policy making and healthcare. The PALS Advisory Board, comprised of influential patient advocacy leaders representing diverse organizations and geographic regions, is collaborating with Dr. Terry McInnis to bring you this educational webinar.
If you would like to learn more about CMM prior to the webinar, please see the following resources:
The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) does not endorse or attest to the quality of the content. Questions regarding content, recordings, and additional information should be directed to the host organization and/or presenter.
More Info Url: